SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies shares surged after the company reported record second-quarter results and significantly raised its full-year revenue and profit guidance, driven by explosive demand for AI-optimized servers. While some traders expressed caution regarding the company's reliance on supplier financing and potential execution risks related to its massive order backlog, retail sentiment remains overwhelmingly bullish on the stock's AI infrastructure growth narrative.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

The community conversation is fragmented, with significant debate over whether the current decline in oil prices represents a long-term bearish trend driven by global supply recovery and reduced demand, or a temporary dip caused by geopolitical manipulation. Traders are actively discussing the impact of ongoing U.S.-Iran tensions on the Strait of Hormuz, with many debating the sustainability of the current peace talks and whether supply chain disruptions will trigger a rebound in crude prices.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to rising oil prices driven by escalating geopolitical tensions and fresh U.S. military strikes on targets near the Strait of Hormuz. Traders are actively debating the potential for further price spikes, with many monitoring the impact of Middle East conflict on global supply and inflation, while others speculate on the likelihood of future ceasefire or diplomatic developments.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense debate over the upcoming Clarity Act vote and persistent concerns regarding monthly escrow token unlocks, which many traders argue exert downward pressure on the price. While some investors remain bullish on institutional adoption and potential price catalysts, others express skepticism, viewing the asset as a speculative instrument vulnerable to dilution and manipulation.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing a tug-of-war between technical consolidation and broader market uncertainty, as traders closely monitor its ability to sustain support at key levels. Discussion remains fragmented, with some participants expressing bullish sentiment due to institutional inflows and potential golden cross signals, while others remain skeptical, focusing on macroeconomic headwinds and broader market volatility.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is seeing significant volatility as traders debate the impact of high short interest and market manipulation, while bulls highlight the company's expansion into AI data centers and its substantial Bitcoin treasury as long-term catalysts. Despite these potential value drivers, sentiment remains divided, with some investors expressing frustration over recent price declines and lack of transparency regarding new tenant agreements.

WorldFinancial

Traders are intensely debating the price direction of WLFI, citing its low float and potential for a short squeeze against a backdrop of ongoing skepticism about its legitimacy. Many remain focused on long-term utility, banking charter prospects, and comparisons to other meme coins, while detractors dismiss it as a fraudulent pump-and-dump scheme associated with the Trump family.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing significant attention from traders anticipating its upcoming earnings, with sentiment divided between those expecting a strong breakout fueled by AI demand and those concerned about potential guidance disappointment. The community is heavily focused on how the company's AI-driven growth and recent infrastructure developments will influence price action following a period of underperformance relative to other semiconductor peers.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

The community conversation is dominated by discussions surrounding Michael Saylor's recent decision to resume Bitcoin purchases, with traders debating whether this strategy is accretive for shareholders or if the company is becoming over-leveraged through dilution. Sentiment remains divided, as some investors view the Bitcoin-centric treasury strategy as a high-conviction long-term bet, while others express skepticism regarding the company's capital management and the potential risks posed by MSCI's proposed index delisting.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors debate the potential outcomes of the Supreme Court remand in the Hikma litigation, with the community divided between hope for a successful refile and concerns over a final dismissal. Discussion is further buoyed by speculative anticipation regarding a forthcoming new drug formulation and its impact on the company's long-term strategic value.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects

ALNY, BMRN, RARE and BBIO offer rare-disease growth potential through strong products, pipeline catalysts and high unmet medical needs.

RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos

Ultragenyx stock rises as Genglycos wins FDA's accelerated approval as the first treatment targeting the underlying cause of GSDIa, boosting its rare-disease portfolio.

Ultragenyx’s Gene-Therapy Win Could Unlock A ‘Long Revenue Tailwind,’ Says Wells Fargo — This Analyst Sees 265% Upside For RARE Stock

Equity

Analysts raised their price targets on RARE stock after the FDA granted accelerated regulatory approval for its rare metabolic disease therapy.


Futures Slide As Treasury Yields Surge, Erasing Bessent Intervention, Driven By Oil Spike

Futures Slide As Treasury Yields Surge, Erasing Bessent Intervention, Driven By Oil Spike

 US futures slide and are trading at session lows,?as bond yields surge after yesterday's Treasury announcement, having now erased the entire post buyback-boost move; yields are 4-5bps higher as...

RARE Stock Jumps 6% After-Hours On First Gene Therapy Approval, New Priority Review Voucher  

The FDA granted accelerated approval to GENGLYCOS, also called DTX401, for patients aged eight and older with glycogen storage disease type Ia (GSDIa). 


RARE Stock Clocks Two Consecutive Days Of Losses Ahead Of Weekend FDA Decision On Gene Therapy 

The FDA is due to rule by August 23 on Ultragenyx’s application for DTX401, a one-time gene therapy for von Gierke disease. 


Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven by higher product sales across its portfolio.

Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Ultragenyx (RARE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of +29.13% and +18.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx Q2 Loss Narrows, Reaffirms 2026 Revenue Outlook

(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) on Tuesday reported a narrower net loss for the second quarter, as revenues grew from a year ago. The company reaffirmed its full-year 2026 revenue guidance...

• Reported GAAP EPS of -$0.90 up 23.08% YoY
• Reported revenue of $214M up 28.53% YoY
• Ultragenyx Pharmaceutical Inc. reaffirms its 2026 full-year total revenue guidance of $730 million to $760 million, excluding potential new product launches, while remaining on track toward profitability in 2027.

Ultragenyx Pharmaceutical Inc. continues to report net losses and a declining cash balance, while maintaining significant structural dependency on third-party partners for the commercialization of its primary revenue-generating product.

Ultragenyx Pharmaceutical Inc. achieved record quarterly revenue and remains on a clear path to profitability by 2027, supported by anticipated expense reductions and a robust pipeline of upcoming clinical catalysts.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$25.81
Prev Close	$25.21
Open	$25.22
Dividend Yield	0.00%
50-Day Moving Average	$28.32
Beta	1.13
Avg. Volume	2.13M
PE Ratio	-4.42

52-Week High	$39.89
52-Week Low	$18.29
Market Capitalization	$2.49B
EPS (Annual)	-$5.83
Price to Book	-8.72
Revenue Per Employee	$490,882.57

Feed

News

Sentiment

Earnings

Fundamentals

Info